Puma Biotechnology reported $4.22M in Net Income for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US $ -94.63M 5.86M
Cerulean Pharma CERU:US $ -9.54M 3.12M
Daiichi Sankyo 4568:JP Y 31853M 4607M
Mirati Therapeutics MRTX:US $ -188.39M 11.23M
Novartis NOVN:VX SF 16308M 13550M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Tg Therapeutics TGTX:US $ -93.34M 7.7M